High economic burden of caring for patients with suspected extraesophageal reflux

American Journal of Gastroenterology

Volumn 108, Issue 6, 2013, Pages 905-911

  Francis, David O ^a   Rymer, Jennifer A ^b   Slaughter, James C ^b   Choksi, Yash ^b   Jiramongkolchai, Pawina ^c   Ogbeide, Evbu ^b   Tran, Christopher ^b   Goutte, Marion ^b   Garrett, C Gaelyn ^a   Hagaman, David ^b   Vaezi, Michael F ^b  

^a Vanderbilt Voice Center   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELASTINE; BECLOMETASONE; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CETIRIZINE; CICLESONIDE; CIMETIDINE; DESLORATADINE; DIPHENHYDRAMINE; ESOMEPRAZOLE; FAMOTIDINE; FEXOFENADINE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LANSOPRAZOLE; LEVOCETIRIZINE; LORATADINE; MOMETASONE FUROATE; OMEPRAZOLE; PANTOPRAZOLE; PSEUDOEPHEDRINE; RABEPRAZOLE; RANITIDINE; TRIAMCINOLONE;

ADULT; ARTICLE; ASTHMA; CONSULTATION; COUGHING; DRUG COST; EXTRAESOPHAGEAL REFLUX; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEDICARE; NOSE DISEASE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; SOCIAL STATUS; SORE THROAT;

AMBULATORY CARE; ASTHMA; COST OF ILLNESS; COUGH; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COSTS; HOARSENESS; HUMANS; MALE; MIDDLE AGED; PHARYNGITIS; PROTON PUMP INHIBITORS;

EID: 84878926024     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.69     Document Type: Article

References (21)

1. Locke 3rd GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal refl ux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 ; 112 : 1448-56. (Pubitemid 27181367)
2. Wiklund I. Quality of life in patients with gastroesophageal refl ux disease. Am J Gastroenterol 2001 ; 96 : S46-53. (Pubitemid 32758209)
3. Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal refl ux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 ; 340 : 825-31. (Pubitemid 29142625)
4. Pare P, Armstrong D, Pericak D et al. Pantoprazole rapidly improves healthrelated quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. J Clin Gastroenterol 2003 ; 37 : 132-8. (Pubitemid 36875573)
5. El-Serag HB, Aguirre TV, Davis S et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004 ; 99 : 1877-83. (Pubitemid 39421227)
6. Fenter TC, Naslund MJ, Shah MB et al. Th e cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care 2006 ; 12 : S90-8.
7. Sandler RS, Everhart JE, Donowitz M et al. Th e burden of selected digestive diseases in the United States. Gastroenterology 2002 ; 122 : 1500-11. (Pubitemid 34465190)
8. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009 ; 136 : 376-86.
9. Vaezi MF, Hicks DM, Abelson TI et al. Laryngeal signs and symptoms and gastroesophageal refl ux disease (GERD): a critical assessment of cause and eff ect association. Clin Gastroenterol Hepatol 2003 ; 1 : 333-44. (Pubitemid 37248052)
10. Kahrilas PJ, Shaheen NJ, Vaezi MF et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal refl ux disease. Gastroenterology 2008 ; 135 : 1383-91, 1391 e1-5.
11. www.cms.gov/apps/physician-fee-schedule/search. In: Center for Medicaid & Medicare Services; 2012.
12. Outpatient Hospital Payments for 61 commonly performed procedures; September 30, 2011;website: http://www.cms.gov/Research-Statistics-Dataand- Systems/Research/HealthCareConInit/HospitalOutpatient.html.
13. Lexi-Comp Online(TM), Lexi-Drugs(TM), Hudson, Ohio: Lexi-Comp, Inc.; February 15, 2012.
14. Eisenberg JM. Clinical economics. A guide to the economic analysis of clinical practices. JAMA 1989 ; 262 : 2879-86. (Pubitemid 20002550)
15. Weinstein MC, Stason WB. Foundations of cost-eff ectiveness analysis for health and medical practices. N Engl J Med 1977 ; 296 : 716-21. (Pubitemid 8066534)
16. http://www.census.gov/compendia/statab/cats/labor-force-employment- earnings.html. U.S. Census Bureau, Accessed March 2012.
17. Vaezi MF. Gastroesophageal refl ux disease and the larynx. J Clin Gastroenterol 2003 ; 36 : 198-203.
18. Cherry J, Siegel CI, Margulies SI et al. Pharyngeal localization of symptoms of gastroesophageal refl ux. Ann Otol Rhinol Laryngol 1970 ; 79 : 912-4.
19. Shaheen NJ, Hansen RA, Morgan DR et al. Th e burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006 ; 101 : 2128-38. (Pubitemid 44337640)
20. Inadomi JM, McIntyre L, Bernard L et al. Step-down from multiple-to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003 ; 98 : 1940-4. (Pubitemid 37185787)
21. Inadomi JM, Jamal R, Murata GH et al. Step-down management of gastroesophageal refl ux disease. Gastroenterology 2001 ; 121 : 1095-100. (Pubitemid 33022089)